Literature DB >> 9502423

Allelic loss of chromosomal arm 8p in breast cancer progression.

R Anbazhagan1, H Fujii, E Gabrielson.   

Abstract

Loss of heterozygosity (LOH) of chromosomal arm 8p has been reported to occur at high frequency for a number of common forms of human cancer, including breast cancer. The objectives of this study were to define the regions on this chromosomal arm that are likely to contain breast cancer tumor suppressor genes and to determine when loss of chromosomal arm 8p occurs during breast cancer progression. For mapping the tumor suppressor gene loci, we evaluated 60 cases of infiltrating ductal cancer for allelic loss using 14 microsatellite markers mapped to this chromosomal arm and found LOH of 8p in 36 (60%) of the tumors. Whereas most of these tumors had allelic loss at all informative markers, five tumors had partial loss of 8p affecting two nonoverlapping regions. LOH for all but one of the tumors with 8p loss involved the region between markers D8S560 and D8S518 at 8p21.3-p23.3, suggesting that this is the locus of a breast cancer tumor suppressor gene. We then studied LOH of 8p in 38 cases of ductal carcinoma in situ (DCIS) with multiple individually microdissected tumor foci evaluated for each case. LOH of 8p was found in 14 of the DCIS cases (36%), including 6 of 16 cases of low histological grade and 8 of 22 cases of intermediate or high histological grade. In four of these DCIS cases, 8p LOH was seen in some but not all of the multiple tumor foci examined. These data suggest that during the evolution of these tumors, LOH of 8p occurred after loss of other chromosomal arms that were lost in all tumor foci. Thus, LOH of 8p, particularly 8p21.3-p23, is a common genetic alteration in infiltrating and in situ breast cancer. Although 8p LOH is common even in low histological grade DCIS, this allelic loss often appears to be preceded by loss of other alleles in the evolution of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502423      PMCID: PMC1858406     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  26 in total

1.  Strong indication for a breast cancer susceptibility gene on chromosome 8p12-p22: linkage analysis in German breast cancer families.

Authors:  S Seitz; K Rohde; E Bender; A Nothnagel; K Kölble; P M Schlag; S Scherneck
Journal:  Oncogene       Date:  1997-02-13       Impact factor: 9.867

2.  Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q.

Authors:  P Devilee; M van Vliet; P van Sloun; N Kuipers Dijkshoorn; J Hermans; P L Pearson; C J Cornelisse
Journal:  Oncogene       Date:  1991-09       Impact factor: 9.867

3.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

4.  Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer.

Authors:  G S Bova; B S Carter; M J Bussemakers; M Emi; Y Fujiwara; N Kyprianou; S C Jacobs; J C Robinson; J I Epstein; P C Walsh
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

5.  Deletion mapping of the short arm of chromosome 8 in non-small cell lung carcinoma.

Authors:  H Ohata; M Emi; Y Fujiwara; K Higashino; K Nakagawa; R Futagami; E Tsuchiya; Y Nakamura
Journal:  Genes Chromosomes Cancer       Date:  1993-06       Impact factor: 5.006

6.  Allelic loss at chromosome band 8p21.3-p22 is associated with progression of hepatocellular carcinoma.

Authors:  M Emi; Y Fujiwara; H Ohata; H Tsuda; S Hirohashi; M Koike; M Miyaki; M Monden; Y Nakamura
Journal:  Genes Chromosomes Cancer       Date:  1993-07       Impact factor: 5.006

7.  Human epithelial ovarian cancer allelotype.

Authors:  W Cliby; S Ritland; L Hartmann; M Dodson; K C Halling; G Keeney; K C Podratz; R B Jenkins
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

8.  Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer.

Authors:  M Emi; Y Fujiwara; T Nakajima; E Tsuchiya; H Tsuda; S Hirohashi; Y Maeda; K Tsuruta; M Miyaki; Y Nakamura
Journal:  Cancer Res       Date:  1992-10-01       Impact factor: 12.701

9.  Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms.

Authors:  M A Knowles; M E Shaw; A J Proctor
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

10.  Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3.

Authors:  C Cunningham; M G Dunlop; A H Wyllie; C C Bird
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

View more
  23 in total

1.  High-resolution physical map and transcript identification of a prostate cancer deletion interval on 8p22.

Authors:  Z H Arbieva; K Banerjee; S Y Kim; S L Edassery; V S Maniatis; S K Horrigan; C A Westbrook
Journal:  Genome Res       Date:  2000-02       Impact factor: 9.043

Review 2.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

3.  The regulation of SOX7 and its tumor suppressive role in breast cancer.

Authors:  Daniel B Stovall; Meimei Wan; Lance D Miller; Paul Cao; Dejan Maglic; Qiang Zhang; Martha R Stampfer; Wennuan Liu; Jianfeng Xu; Guangchao Sui
Journal:  Am J Pathol       Date:  2013-09-05       Impact factor: 4.307

4.  Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer.

Authors:  B I Sigbjörnsdottir; G Ragnarsson; B A Agnarsson; C Huiping; R B Barkardottir; V Egilsson; S Ingvarsson
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

5.  The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors.

Authors:  H Ishii; R Baffa; S I Numata; Y Murakumo; S Rattan; H Inoue; M Mori; V Fidanza; H Alder; C M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

Review 6.  SOX7: from a developmental regulator to an emerging tumor suppressor.

Authors:  Daniel B Stovall; Paul Cao; Guangchao Sui
Journal:  Histol Histopathol       Date:  2013-11-29       Impact factor: 2.303

7.  Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells.

Authors:  Lizheng Guo; Diansheng Zhong; Stephen Lau; Xiuju Liu; Xue-Yuan Dong; Xiaodong Sun; Vincent W Yang; Paula M Vertino; Carlos S Moreno; Vijay Varma; Jin-Tang Dong; Wei Zhou
Journal:  Mol Cancer Res       Date:  2008-09       Impact factor: 5.852

8.  Palmitoylation of cytoskeleton associated protein 4 by DHHC2 regulates antiproliferative factor-mediated signaling.

Authors:  Sonia L Planey; Susan K Keay; Chen-Ou Zhang; David A Zacharias
Journal:  Mol Biol Cell       Date:  2009-01-14       Impact factor: 4.138

9.  Identification of CKAP4/p63 as a major substrate of the palmitoyl acyltransferase DHHC2, a putative tumor suppressor, using a novel proteomics method.

Authors:  Jun Zhang; Sonia L Planey; Carolina Ceballos; Stanley M Stevens; Susan K Keay; David A Zacharias
Journal:  Mol Cell Proteomics       Date:  2008-02-22       Impact factor: 5.911

10.  Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.

Authors:  Justin M Balko; Luis J Schwarz; Neil E Bhola; Richard Kurupi; Phillip Owens; Todd W Miller; Henry Gómez; Rebecca S Cook; Carlos L Arteaga
Journal:  Cancer Res       Date:  2013-08-21       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.